Greenwich LifeSciences, Inc. (GLSI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 15, 2021, reports the results of the Annual Meeting of Stockholders held by Greenwich LifeSciences, Inc. on that date. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol GLSI.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 10,540,382 shares were represented at the meeting, constituting a quorum. The following matters were submitted to a vote:
- Proposal 1: Election of Directors All five nominees were elected to serve until the 2022 Annual Meeting.
- David McWilliams: 9,368,038 For, 0 Against, 603,421 Abstain.
- Snehal S. Patel: 9,866,004 For, 0 Against, 105,455 Abstain.
- Eric Rothe: 9,385,674 For, 0 Against, 585,785 Abstain.
- F. Joseph Daugherty, M.D.: 9,817,393 For, 0 Against, 154,066 Abstain.
- Kenneth Hallock: 9,689,781 For, 0 Against, 281,678 Abstain.
- Proposal 2: Ratification of Independent Auditor The appointment of Malone Bailey, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2021, was ratified.
- Votes: 10,523,113 For, 6,200 Against, 11,069 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the full composition of the newly elected Board of Directors and their tenure terms.
- Confirm the engagement of Malone Bailey, LLP for the 2021 fiscal year audit.
- Review the Definitive Proxy Statement filed on October 19, 2021, for detailed background on the proposals.
- Note that 568,923 shares were recorded as Broker Non-Votes for the director elections.